Market revenue in 2023 | USD 31,029.0 million |
Market revenue in 2030 | USD 64,815.2 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Pharmaceutical industry was the largest segment with a revenue share of 43.04% in 2023. Horizon Databook has segmented the Global in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounted for the major share of the global in-vitro toxicology testing market owing to the increased focus of government bodies on drug discovery, rise in healthcare expenditure, and the presence of adequate infrastructure for the growth & development of drug discovery technologies.
Recent advancements and new government regulations pertaining to drug development have contributed to the rapid launch of novel, cost-effective, nonanimal testing approaches for the safety testing of new products across various industries including devices, chemicals, and cosmetics.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account